VYNE Therapeutics Inc. (VYNE) NASDAQ
0.64
-0.0071(-1.10%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.64
-0.0071(-1.10%)
Currency In USD
| Market Cap | 24.81M |
| Enterprise Value | 782,716 |
| P/E Ratio | -1.03 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 18.72 |
| Price/Book Ratio | 0.99 |
| Enterprise/Revenue | -23.44 |
| Enterprise/EBITDA | 0.45 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -46.46 |
| Operating Margin | -52.19 |
| Return On Assets | -0.88 |
| Return On Equity | -0.74 |
| Revenue | 570,000 |
| Revenue/Share | 0.01 |
| Gross Profit | 547,000 |
| EBITDA | -26.73M |
| Net Income | -26.48M |
| Diluted EPS | -0.62 |
| Total Cash | 29.01M |
| Total Cash/Share | 0.68 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 12.53 |
| Book Value Per Share | 0.65 |
| 52-Week Change | -65.21 |
| 52-Week High | 1.99 |
| 52-Week Low | 0.28 |
| Moving Average 50 Days | 0.6 |
| Moving Average 200 Days | 0.53 |
| Average Volume | 278,218 |
| Shares Outstanding | 16.66M |
| % Held by Institutions | 19.14 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:18 |
| Last Split Date | February 13, 2023 |